Ashland Global Holdings Inc
NYSE:ASH

Watchlist Manager
Ashland Global Holdings Inc Logo
Ashland Global Holdings Inc
NYSE:ASH
Watchlist
Price: 71.39 USD -0.03%
Market Cap: 3.4B USD
Have any thoughts about
Ashland Global Holdings Inc?
Write Note

Ashland Global Holdings Inc
Investor Relations

Ashland Global Holdings Inc., a company with a long-standing history, has gracefully evolved from its roots as a diversified conglomerate into a focused chemical specialist. Originally founded in the early 20th century, Ashland navigated through decades of transformation and divestitures, honing its expertise to become a key player in the specialty chemicals industry. With a strategic emphasis on high-performance materials and ingredients, the company's operations pivot around crafting unique chemical solutions that cater to diverse sectors, including pharmaceuticals, personal care, and food and beverage. By prioritizing innovation and sustainability, Ashland consistently develops advanced formulations and specialty additives that deliver tangible benefits in product performance, thus creating a competitive edge in the market.

The company's revenue machine churns primarily through its robust portfolio of specialty chemicals, which play essential roles as enhancers and stabilizers in various products. For instance, Ashland's pharmaceutical and health-related polymers are pivotal in drug formulations, offering superior consistency and quality that manufacturers rely on. Additionally, its personal care ingredients, renowned for enhancing the sensory and functional attributes of beauty products, generate substantial portions of its earnings. By embedding itself deeply into the supply chains of high-growth industries, Ashland Global Holdings not only solidifies lasting relationships with its clients but also continuously adapts to market demands and trends, ensuring its products remain indispensable in their respective fields. Through this strategic alignment of innovation, customer focus, and operational excellence, Ashland sustains its financial health and profitability in the fluctuating chemical markets.

Show more

Earnings Calls

Show Transcript
Previous
Next
Loading

Management

Mr. Guillermo Novo
Chairman & CEO
No Bio Available
Mr. John Kevin Willis
Senior VP & CFO
No Bio Available
Dr. Osama M. Musa Ph.D.
Senior VP & CTO
No Bio Available
Mr. Karl R. Bostaph
Senior Vice President of Operations
No Bio Available
Mr. Eric N. Boni
VP of Finance & Principal Accounting Officer
No Bio Available
Mr. William C. Whitaker C.F.A.
Director of Investor Relations
No Bio Available
Ms. Robin E. Lampkin
Senior VP, General Counsel & Secretary
No Bio Available
Ms. Eileen M. Drury
Senior VP & Chief HR Officer
No Bio Available
Mr. James Minicucci
Senior VP & GM of Personal Care
No Bio Available
Ms. Alessandra Faccin Assis
Senior VP and GM of Life Sciences & Intermediates
No Bio Available

Contacts

Address
DELAWARE
Wilmington
8145 Blazer Drive
Contacts
+13049953000.0
www.ashland.com